SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-040557
Filing Date
2023-04-03
Accepted
2023-04-03 08:15:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm239318d1_sc13g.htm SC 13G 41059
  Complete submission text file 0001104659-23-040557.txt   42271
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93555 | Film No.: 23790728
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 REICHAN STREET EVEN YEHUDA L3 4050708
Business Address
Peters Thomas Phineas (Filed by) CIK: 0001971606 (see all company filings)

Type: SC 13G